Table 1.
Clinical and metabolic features between normal controls and type 2 diabetic subjects in the present study.
| Non-DM (n = 69) | DM (n = 38) | P value∗ | |
|---|---|---|---|
| Age (years) | 17.3 ± 3.8 | 18.6 ± 6.6 | 0.289 |
| BMI percentiles | 56.7 ± 29.0 | 83.8 ± 15.4 | <0.001 |
| Glucose (mmol/L) | 5.19 ± 0.40 | 10.65 ± 4.05 | <0.001 |
| TCH (mmol/L) | 4.05 ± 0.77 | 4.22 ± 1.02 | 0.4159 |
| TG (mmol/L) | 0.74 ± 0.26 | 1.17 ± 0.45 | 0.0005 |
| HDL (mmol/L) | 1.43 ± 0.39 | 1.20 ± 0.50 | 0.0320 |
| Fasting insulin (pmol/L) | 7.66 ± 4.47 | 17.99 ± 20.43 | 0.0043 |
| HOMA-IR | 1.78 ± 1.06 | 7.48 ± 8.09 | <0.001 |
| Log (HOMA-IR) | 0.402 ± 0.624 | 1.449 ± 1.143 | <0.001 |
| HOMA-B | 94.62 ± 58.17 | 94.13 ± 168.52 | 0.987 |
| Log (HOMA-B) | 4.372 ± 0.625 | 3.490 ± 1.458 | 0.001 |
| Sex (M : F) | 26 : 43 | 20 : 18 | 0.157$ |
*P value with Student's t-test.
$By chi-squared test.
BMI percentiles: body mass index age- and sex-specific percentiles; TCH: total cholesterol; TG: triglyceride; HDL: high density lipoprotein-cholesterol; HOMA-IR: homeostasis model assessment-insulin resistance; HOMA-B: homeostasis model assessment-β cell.